(2020). Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Ann Intern Med, 173, 417-425. http://doi.org/10.7326/m20-0289
. K. Filion
First name
K.
Middle name
B.
Last name
Filion
(2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021
. (2023). Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2975
. (2023). Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15106
. (2023). SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15787
. (2023). Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population-based cohort study. Diabet Med, e15108. http://doi.org/10.1111/dme.15108
. (2023). Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15000
. (2022). Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study. Plos One, 17, e0277623. http://doi.org/10.1371/journal.pone.0277623
. (2022). Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1584
. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. Bmc Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1
.